Psoriatic spondyloarthritis and Sjögren syndrome: a casual association?

Submitted: 6 April 2020
Accepted: 18 July 2020
Published: 19 November 2020
Accepted: 18 July 2020
Abstract Views: 1060
PDF: 629
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- P. Fadda, L. La Civita, A.L. Zignego, C. Ferri, A clinico-serological investigation of arthritis in patients with or without cryoglobulinemic syndrome , Reumatismo: Vol. 54 No. 4 (2002)
- S. Chandrashekara, V. Shobha, B.G. Dharmanand, R. Jois, S. Kumar, K.M. Mahendranath, V. Haridas, S. Prasad, Y. Singh, M.A. Daware, A. Swamy, R. Subramanian, S.A. Somashekar, A.M. Shanthappa, K.R. Anupama, Comorbidities and related factors in rheumatoid arthritis patients of south India- Karnataka Rheumatoid Arthritis Comorbidity (KRAC) study , Reumatismo: Vol. 69 No. 2 (2017)
- F. Salaffi, A. Ciapetti, P. Sarzi Puttini, F. Atzeni, C. Iannuccelli, M. Di Franco, M. Cazzola, L. Bazzichi, Preliminary identification of key clinical domains for outcome evaluation in fibromyalgia using the Delphi method: the Italian experience , Reumatismo: Vol. 64 No. 1 (2012)
- M. Cutolo, IL-1Ra: its role in rheumatoid arthritis , Reumatismo: Vol. 56 No. s1 (2004)
- M. Ferrito, G. Cincinelli, M. Manara, R. Di Taranto, E.G. Favalli, R. Caporali, Retention rate of tumor necrosis factor inhibitors, anti-interleukin 17, and anti-interleukin 12/23 drugs in a single-center cohort of psoriatic arthritis patients , Reumatismo: Vol. 75 No. 2 (2023)
- A. Ghirardello, A. Doria, S. Zampieri, D. Villalta, R. Tozzoli, L. Iaccarino, R. Bendo, P.F. Gambari, Detection of serum anti-B/B’ UsnRNP antibodies in patients with connective tissue diseases by immunoblotting , Reumatismo: Vol. 54 No. 4 (2002)
- I. Olivieri, E. Scarano, A. Padula, S. D'Angelo, IMAGING OF PSORIATIC ARTHRITIS , Reumatismo: Vol. 59 No. s1 (2007)
- I. Olivieri, Salvatore D'Angelo, C. Palazzi, P. Leccese, A. Nigro, A. Padula, Anti-TNF agents for the treatment of active non-radiographic axial spondyloarthritis , Reumatismo: Vol. 65 No. 1 (2013)
- S. Mancuso, M. De Michele, S. Truglia, A. Capozzi, L. Rapino, I. Berto, C. Alessandri, D. Toni, V. Manganelli, M. Sorice, F. Conti, Cryptogenic stroke and seronegative antiphospholipid syndrome: a case series of patients with positivity for “non-criteria” antiphospholipid antibodies , Reumatismo: Vol. 76 No. 4 (2024)
- A. Calligaro, A. Hoxha, A. Ruffatti, L. Punzi, Are biological drugs safe in pregnancy? , Reumatismo: Vol. 66 No. 4 (2014)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
You may also start an advanced similarity search for this article.